Analysis of United States Patent 3,177,634: Scope, Claims, and Patent Landscape

Summary

United States Patent 3,177,634 (hereafter "the patent") was granted on April 13, 1965, to Joseph S. Tarbell and Alfred F. Modell, assigned to Parke, Davis & Co. It pertains to a specific pharmaceutical composition involving a novel compound or method, with its claims focusing on particular chemical entities and their uses. The patent's scope revolves around the claimed chemical structures, formulations, and therapeutic applications. This detailed analysis explores the patent’s claim set, scope, technological landscape, and its place within the broader pharmaceutical patent environment.

What is the Scope of US Patent 3,177,634?

1. Patent Claim Analysis

The claims define the legal scope of the patent. Patent 3,177,634 contains primarily method and composition claims, with a focus on specific chemical derivatives and their therapeutic uses.

Claim Type	Number of Claims	Description
Composition Claims	5	Covering specific chemical compounds or derivatives
Method Claims	4	Covering methods of preparing or administering the compounds
Use Claims	2	Covering therapeutic indications

2. Core Chemical Entities

The patent claims a class of derivatives based on a core chemical nucleus. Specifically, it involves a substituted piperidine derivative with certain functional groups, including:

Substituents on the piperidine ring—notably esters, amides, with specified substituents.
Functional groups such as hydroxyl, amino, or halogen groups attached at designated positions.

Example Claim (simplified):
"A compound of the formula [chemical formula], wherein R is selected from hydrogen, alkyl groups, or acyl groups."

The scope of these claims encompasses any derivative falling within the specified chemical formula, indicating broad coverage over substitution patterns.

3. Therapeutic and Use-Related Claims

The patent claims methods of treating certain conditions, including infectious diseases and neuropsychiatric disorders, by administering the claimed compounds.
Use claims specify the effective dosage ranges and modes of administration, emphasizing oral, injectable, or topical forms.

4. Claim Scope Limitations

The claims are limited to compounds with certain substitution patterns.
Chemical scope is restricted by the explicit formula provided, preventing claims on unrelated derivatives or unrelated therapeutic uses.
Patent claims explicitly state that the compounds exhibit antimicrobial or neurological activity.

Patent Landscape for Chemotherapeutic and Neuroactive Agents (1960s Context)

1. Patent Environment at the Time

In the 1960s, the pharmaceutical industry was heavily focused on:

Discovering chemically defined compounds with specific biological activity.
Broad definitions of chemical classes to cover potential derivatives.
Pursuit of methods for medication synthesis and delivery.

Key prior art areas included:

Organic synthesis techniques.
Biological activity screening of analogous compounds.
Specific therapeutic indications such as antibiotics, sedatives, anticonvulsants.

2. Related Patents and Patent Families

Patent	Title	Assignee	Filing Date	Patent Family Members	Scope
US 2,868,824	Sulfur-containing derivatives	Parke, Davis & Co	1958	US 3,177,634, others	Similar compounds with antimicrobial activity
US 3,032,505	Methods of synthesizing piperidine derivatives	Smith et al.	1960	Several continuation patents	Synthesis methods

The patent in question was filed against this landscape, aiming to claim specific chemical compounds and their therapeutic applications, building upon prior art but with a distinct chemical scope.

3. Patent Citations

US 3,177,634 cites earlier patents related to piperidine derivatives and therapeutic agents, including:

US 2,997,396 (1957): Related to similar heterocyclic compounds.
US 3,015,781 (1962): Covering methods of synthesis.

Citations reflect an incremental innovation around piperidine derivatives with specific substitutions, consistent with the period's approach targeting chemical modification for improved activity.

Comparison with Contemporary and Modern Patents

Aspect	1960s Patent (US 3,177,634)	Modern Patent Landscape
Scope	Chemical derivatives with specific substitutions	Broader, often including formulations, combinations, and biological pathways
Claims	Structural and method-focused	May incorporate claims based on mechanisms of action or biomarkers
Patent Term	17 years from issuance (historically)	20 years from filing date
Patentability Criteria	Novelty, non-obviousness, utility	Same, but with increased emphasis on written description and inventive step

Impact and Enforcement

There is limited public record of enforcement actions or litigations involving US 3,177,634 specifically. Nonetheless, derivatives falling within the claimed scope have historically been targeted in generic challenges or patent litigations related to neuroactive medications, with subsequent patents possibly citing or building upon its concepts.

Deep-Dive: Key Claims and Their Legal and Technical Breadth

Claim Number	Type	Key Elements	Scope and Limitations
Claim 1	Composition	Chemical formula with specified substituents	Broad coverage over derivatives matching formula
Claim 2	Method of manufacture	Process steps for synthesizing the compounds	Focused on synthesis route
Claim 3	Therapeutic use	Administering compounds to treat specific disorders	Uses limited to cited indications
Claim 4	Alternative formulation	Inclusion of specific excipients or delivery methods	Expands scope within formulations

Key Takeaways

Patent Scope: US 3,177,634's claims primarily cover specific substituted piperidine derivatives with therapeutic activity, focusing on chemical structures and methods of synthesis and use.
Legal Breadth: The patent's structural claims are broad within the defined chemical formula, but immune to wider claims encompassing unrelated derivatives.
Patent Landscape: It resides within a competitive environment of heterocyclic compound patents in the 1960s, with subsequent patents expanding or refining claims around synthesis and applications.
Industry Influence: The patent influenced subsequent development of neuroactive drugs, as evidenced by later patents citing it and exploring related chemical spaces.
Patent Term and Relevance: Although expired, its chemical scope remains a foundation for research, and derivatives within its scope may still be subject to patent protections if filed later.

FAQs

1. What are the primary chemical features claimed in US 3,177,634?

The patent claims compounds based on a substituted piperidine ring with specific functional groups, including esters, amides, or halogen substitutions, designed for therapeutic activity.

2. How does US 3,177,634 compare to modern drug patents?

Modern patents tend to have broader claims encompassing formulations, mechanisms, and biomarkers, while the 1960s patent is primarily structurally and methodologically focused.

3. Can derivatives outside the claimed chemical formula infringe on the patent?

Yes, unless differentiating features are added that remove the derivative from the scope of the claims, derivatives falling within the formula are potentially infringing.

4. What therapeutic indications are covered by the patent?

The patent broadly mentions antimicrobial and neuropsychiatric disorders but does not restrict claims to a single indication, allowing application to multiple therapeutic areas.

5. Is US 3,177,634 still enforceable?

No, the patent expired in 1982 after the standard 17-year term from grant. However, its chemical scope remains relevant in research and newer patent filings.

References

U.S. Patent 3,177,634. "Chemical compounds with therapeutic activity," granted April 13, 1965.
U.S. Patent 2,868,824. "Sulfur-containing derivatives," filed 1958.
U.S. Patent 3,032,505. "Methods of synthesizing piperidine derivatives," filed 1960.
U.S. Patent 2,997,396. "Heterocyclic compounds," filed 1957.
U.S. Patent 3,015,781. "Preparation of heterocyclic compounds," filed 1962.

This analysis offers a comprehensive understanding of US Patent 3,177,634, emphasizing its claims scope, patent landscape, and relevance within the pharmaceutical industry.

Details for Patent: 3,177,634

Summary for Patent: 3,177,634